Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Mary Tolaro v. Deborah Dunsire et al
Case Number:
8:14-cv-01800
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
February 11, 2015
Allergan Shareholder Withdraws Suit Over Spurned Valeant Bid
The plaintiff suing Allergan Inc.'s board of directors for failing to properly consider Valeant Pharmaceuticals International Inc.'s takeover bid on Wednesday decided to voluntarily dismiss the derivative class action, citing Valeant's decision to withdraw its own offer.
-
November 13, 2014
Derivative Suit Faults Allergan Board For Rejecting Valeant Bid
Allergan Inc.'s board of directors was hit with a new shareholder derivative class action in California federal court Wednesday alleging they failed to properly consider Valeant Pharmaceuticals International Inc.'s takeover bid as the Botox maker continues merger talks with another potential buyer.